

Valthos
Valthos applies frontier AI capabilities to the field of biodefense and biosecurity. The platform is designed to rapidly detect novel biological threats and computationally design medical countermeasures, such as vaccines or neutralizing antibodies, in real-time. Valthos acts as a digital shield, using predictive modeling to prepare for and mitigate emerging biological risks. The approach compresses traditional R&D timelines, offering systemic cost reductions in therapeutic development and biological engineering.
Biotechnology
·
Hybrid·
11-50·
$30M Seed
















